Pharmaceutical Industry is Committed to Big Data to Optimise Use of Health Information

IMI Big Data for Better Outcomes program (BD4BO) are looking to maximise the potential of the large amounts of data generated by the healthcare sector and promote the evolution of health systems towards value-based models.

This program is already being developed in four specific pathologies (Alzheimer’s, hematological neoplasias, multiple sclerosis and cardiovascular diseases), in which the research teams involved intend to use the Big Data to integrate data that allow to answer the most pressing problems of these Diseases, develop more effective treatments and facilitate decision-making.

Read the full article story here.

Tagged with

Published 10. March 2017 in News EU, News Spain